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LETTERS TO THE EDITOR 
Incremental Prognostic Value of 
Single-Photon Emission 
Computed Tomography 
The report by Palmas et al. (1) in a recent issue of the Journal is 
incomplete. Interpretation ofthe study requires additional information 
about model adequacy and the methods used to assemble, follow and 
measure the study sample. 
The authors used the terms Cox regression and logistic regression 
interchangeably. According to the methods ection, they used Cox 
regression; however, they reported adjusted odds ratios and implied in 
the study limitations ection that they used logistic regression. Al- 
though the Cox and logistic techniques produce similar results when 
duration of follow-up, event rate and censoring are appropriately 
constrained, the procedures are not synonymous. The former models 
the hazard rate, accommodates censoring and estimates relative risks; 
the latter models cumulative hazard to a fixed point in time, ignores 
actual survival time and estimates odds ratios, which may or may not 
approximate r lative risks in a given context.* 
If Palmas et al. used Cox regression, then they modeled the 
cause-specific hazard. If some deaths were noncardiac, they assumed 
independent competing risks. This is a strong assumption, considering 
that the mechanism ofloss to follow-up was probably not end-of-study 
censoring and that the prognosis of the patients may have varied 
systematically over the long enrollment and follow-up period. If the 
assumption was invalid, the cause-specific hazard does not have the 
usual survival probability interpretation. Dependent competing risks 
can, in theory, distort he estimated prognostic effect o the point of 
reversing its sign; that is, the direction of the estimated clinical effect. 
Valid interpretation ofthe adjusted analyses requires adescription of 
the censoring mechanism as well as a list of the noncardiac causes of 
death and their observed incidence. 
Cause-specific mortality data are unreliable (2-4); yet there is 
nothing to indicate that the authors recognized or attempted to 
minimize this problem. To this end, they should describe the protocol 
that they used to ascertain cause of death and provide details about its 
implementation: forexample, What rules did they use to classify cause 
of death? Were the rules applied by independent observers who were 
blinded to the single-photon emission computed tomographic 
(SPECT) results? Did they attempt to corroborate information derived 
from death certificates and medical record face sheets? What source 
took precedence when there were multiple sources of data concerning 
cause of death? How were deaths handled when the cause was 
uncertain? 
The validity of the Cox model also depends on the legitimacy of the 
proportionality assumption; that is, the assumption that the hazard 
associated with different covariate patterns is constant over time. 
Proportional hazards, like independent competing risks, is a strong 
statistical assumption. It can and should be tested. There is no 
evidence in the report by Palmas et al. that it was. Failure to 
demonstrate hat the model was a reasonable representation f the 
data further obfuscates the meaning of the SPECT coefficients. 
Patient enrollment and testing in the study spans different hera- 
*A direct estimate ofrelative risk can also be derived with logistic regression 
in cohort studies. 
peutic eras. Fifteen years elapsed between the time that the first 
patient was enrolled in the data base and the last patient underwent 
SPECT testing. The authors have tacitly assumed that there were no 
significant secular trends in the relation between known and unknown 
as well as measured and unmeasured postbypass prognostic ndicators. 
This strong assumption is unrealistic in light of the profound changes 
in cardiovascular medicine since 1975 when the first study patient 
underwent coronary artery bypass graft surgery. The impact of secular 
trends on this analysis warrants investigation. 
The results of the regression depend on the investigators' choice of 
candidate variables. They chose to evaluate the incremental prognostic 
value (beyond historical and treadmill data) of thallium-201 SPECT in 
patients ---5 years after bypass urgery; however, the substantive 
question is whether SPECT testing provides incremental predictive 
value after accounting for routinely available prognostic indicators. In 
the preamble to the methods section, the authors list prognostic factors 
that are routinely available in postbypass patients, including extent and 
severity of disease in the native vessels as well as left ventricular 
function; however, they ignored these in the analysis. It is impossible to 
gage the impact of this oversight without additional data; however, 
depending on the correlations between covariates, inclusion of these 
factors in the regression could abolish the SPECT effects. 
Palmas et al. disregarded several other modeling issues despite 
relying on an esoteric statistical paradigm that is probably incompre- 
hensible to most readers of the Journal. 1) They made the tacit 
assumption that the adjusted relative risks are multiplicative. 2)They 
evaluated the plausibility of the assumption, that there is an exponen- 
tial relation between continuous covariates and event rate, for only one 
of the reported continuous variables. 3) There is no indication that 
they searched for influential observations. 4) They did not describe 
variable scoring; thus, it is possible that they treated ordinal, and 
possibly nominal covariates, as interval data without offering a justifi- 
cation. 5) They did not investigate he stability of the model despite the 
possibility of a) multicollinearity, related to variables like the SPECT 
scores, and b) latent overfitting (i.e., the ratio of the number of hard 
events to the number of candidate variables appears to be considerably 
<10 to 1). 
Questions regarding the validity of the statistical procedure not- 
withstanding, the study sample may not be an inception cohort. The 
use of an inception cohort minimizes selection of patients who are at 
particularly high or low risk for the event(s) of interest. Failure to 
assemble a proper inception cohort, and to obtain complete follow-up 
on it, "usually constitutes a fatal flaw" in prognostic studies (5). 
Consequently, a vague description of the assembly process is a major 
deficiency in prognostic studies. This is particularly true in retrospec- 
tive analyses, where it is more difficult o know whether all patients 
who should have been counted were actually counted. 
In this case, the description of the criteria and methods used to 
assemble the study sample is inadequate. The authors evaluated 
patients who underwent routine SPECT testing at least 5 years after 
bypass urgery. However, they did not stipulate that this included all 
patients who underwent routine SPECT, at least 5 years after bypass, 
at the institution in question. Moreover, they did not define "routine" 
SPECT testing. Referral for SPECT was not routine in the ordinary 
sense because only 8% of the patients in the data base had it. In 
addition, there is, in the methods ection, a 741 patient difference 
between references to the total number of bypass patients; does the 
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smaller number eflect he subset of data base patients without missing 
data? The apparent completeness of retrospective data can be a 
reporting artifact, that is, the data manager may have selected a subset 
of patients who had complete data on all study variables or the authors 
may have reported the number of patients who had SPECT testing, as 
opposed to the number of patients who contributed to estimation of 
the regression coefficients; that is, only patients with complete data on 
all candidate variables contribute to estimation of regression coeffi- 
cients in the proportional hazards model. The latter appears to be the 
case (e.g., in Table 3, the electrocardiographic response to exercise was 
available in only 281 of the 294 patients). 
To thoroughly characterize the sample, the authors hould report 
the inclusion/exclusion criteria for the data base, as well as the analysis. 
They should demonstrate hat covariates were measured at a uniform 
time, relative to bypass urgery, in all patients, with a summary of the 
distributions of time from bypass to measurement of historical, stress 
test and SPECT variables. In addition, they should recapitulate the 
indications for SPECT testing in the sample, and they should report 
the prescripts for terminating patient follow-up, as well as indicate the 
proportion of patients whose final data base entry was the last posting 
before loss of contact with data base personnel. They should also 
disclose the proportion of patients and events that were excluded by 
the regression algorithm. 
The admonition at the end of the conclusions ection would be 
adequate if the study design and analysis were beyond reproach. As it 
stands we do not know 1) how many patients there were or how they 
got into the analysis; 2) why they underwent bypass and SPECT 
testing; 3) how many were lost to follow-up and why; 4) accuracy of the 
cause of death assignment; 5) reliability of the regression coefficients; 
and 6) appropriateness of the statistical model. In short, in its present 
form the report adds little to the current state of knowledge regarding 
late prognostication after bypass urgery. It remains to be determined 
whether the observed increment in information is genuine and not, as 
suggested by the authors, whether it justifies the cost of thallium scans 
in these patients. 
JOHN G. FERGUSON, MD 
Director of Clinical Epidemiology 
Memphis Vascular Research Foundation 
910 Madison Avenue, Suite 710 
Memphis, Tennessee 38103 
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Reply 
We appreciate Ferguson's comments with respect to our recent report 
(1). Ferguson outlines in great detail the various necessary steps for 
performing a prognostic study and raises questions regarding the 
epidemiologic and statistical validity of our analyses. 
In our study, we used the Cox proportional hazards analysis 
throughout. We inadvertently abeled Table 4 as showing the odds 
ratio when, as Dr. Ferguson pointed out, risk ratio or relative risk 
would have been the correct label. We similarly referred to the logistic 
model in the limitations ection of the discussion; Again, this is a 
misstatement, and the Cox proportional hazards analysis hould have 
been mentioned instead. We apologize for these inaccuracies. 
Statistical considerations. Although not specified in the report, the 
assumption of proportionality of hazards was tested, and variables 
were assessed for influential observations. The stability of the model 
was also investigated in a manner similar to that previously suggested 
by Ferguson et al. (2) and Diamond (3). Specifically, overfitting was 
scrupulously avoided by performing the regression analysis on only 
four variables, given the 41 observed events of interest. Furthermore, 
all variables were inspected for collinearity before entry into the 
model. In the case of highly related variables, only one of the two were 
introduced into the model. The variables entered into the Cox 
proportional hazards model were selected on statistical grounds; that 
is, no variables were entered or forced into a model based on previous 
performance or assumption. With respect o cardiac catheterization 
variables, only a minority of patients had a catheterization in close 
temporal proximity to their test date; thus, this information was not 
used in our analyses. All patients had catheterization data from the 
time of their bypass surgery, but these data would no longer be 
accurate. A small portion of the patient population had missing 
information; those variables with missing values were not included in 
the multivariate analysis but patients with missing data were not 
excluded from the multivariate analysis. No detectable trends were 
found with respect o these missing values. Ordinal data were evalu- 
ated as such in the multivariate model, and scores were treated as 
interval data. 
Epidemiologic onsiderations. Dr. Ferguson raised a number of 
questions regarding patient selection, follow-up and determination f 
events. The patients were selected in the following manner: We 
identified all patients who had undergone xercise thallium single- 
photon emission computed tomography (SPECT) at least 5 years after 
their coronary artery bypass surgery. Ferguson correctly states that 
identification of all potentially eligible patients is crucial in this step. 
We have found that <5% of patients are missed by the searching 
techniques used for this study. The discrepancy between the patient 
numbers cited for the total population who had undergone bypass 
during the time interval of our study is explained by our reference to 
two different intervals; 3,741 patients underwent bypass between 
November 12, 1975 and December 27, 1984. A larger group of 4,186 
patients were assembled in response to a reviewer's comments asking 
for the comparisons made in Table 2. The time interval used to define 
the 4,186 patients was inadvertently extended to patients who under- 
went bypass up to August 1, 1986. This error is limited to the analyses 
shown in Table 2, and probably did not materially affect the results 
shown. 
Secular considerations. With respect to Ferguson's comments 
regarding the time span of this study, the purpose of the study was "to 
assess the incremental prognostic value..,  of thallium-201 myocardial 
perfusion single photon emission tomography in patients ->5 years 
after bypass urgery" (1) rather than to assess the efficacy of bypass 
surgery itself. The study period examined was that between the date of 
the nuclear test (between June 1987 and September 1990) and the last 
follow-up date (rather than the time between initial bypass date and 
last date of follow-up). Thus, a maximal interval of <6 years elapsed 
during which the population was followed up (rather than the 15 years 
stated in the letter). We believe that this time period is too short for 
secular trends to have impacted on our group. Contrary to Ferguson's 
comments, no major changes in patient treatment or management over 
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this 6-year period have occurred in our institution. Because the 
patients that we examined had their nuclear tests performed over a 
temporally limited period at the same institution, had a high rate of 
successful follow-up and were not affected by secular trends, the study 
population meets the conventional criteria typical of an inception 
cohort (4). 
Follow-up considerations. All patients included in the study had 
undergone thallium-201 myocardial perfusion SPECT at least 1 year 
before being contacted for follow-up. Follow-up was performed by 
scripted telephone interview by people with no knowledge of the 
patient's test results. In the case of patients or patient's next of kin who 
stated that either hard events (myocardial infarction or cardiac death) 
or interventions (cardiac catheterization, coronary artery bypass sur- 
gery, percutaneous transluminal coronary angioplasty) had occurred, 
these events were confirmed by hospital records or the physician's 
office records. All hard events were confirmed by check of hospital and 
private doctor's office records by people with no knowledge of the 
patient's test results. 
Myocardial infarctions were similarly confirmed by the presence of 
appropriate cardiac enzyme and electrocardiographic changes. Our 
lost to follow-up rate of <5% in this population is testimony to our 
success in contacting patients, We agree with Ferguson that the 
determination of the exact cause of death is imprecise, but all efforts 
were made to derive the most accurate final diagnosis possible. 
Despite the numerous criticisms of Ferguson, we believe that the 
conclusions reached by our study are valid and that the study provides 
new prognostic information in an important but infrequently studied 
patient group. Ferguson raises points regarding the performance of 
multivariate survival analysis that should be asked when any such study 
is read. Although there is a need to ensure that published statistical 
analyses are performed correctly, the methodologic descriptions of 
advanced statistical analyses (as that for SPECT imaging and process- 
ing) are usually excised from the final manuscript due to the page 
limitations placed on clinical journals, A complete methods ection 
from such a manuscript may well reach the length of Ferguson's letter. 
Finally, the level of methodologic detail provided in our report is 
typical of that of other investigators in and out of our field (5-14). 
RORY HACHAMOVITCH, MD 
DEBRA SCARLATA, MS 
GEORGE A. DIAMOND, MD, FACC 
HOSEN KIAT, MD, FACC 
DANIEL S. BERMAN, MD, FACC 
Department of Imaging 
Cedars-Sinai Medical Center 
8700 Beverly Boulevard, Room A041 
Los Angeles, California 90048 
References 
l. Palmas W, Bingham S, Diamond GA, et al. Incremental prognostic value of exercise 
thallium-201 myocardial single-photon emission computed tomography late after coronary 
artery bypass surgery. J Am Coil Cardiol 1995;25:403-9. 
2. Ferguson JG, Pollock BH, Work JW, Diamond GA. How does ample size affect he 
reproducibility of a clinical prediction rule? [abstract] Clin Res 1987;35:344A. 
3. Diamond GA. Future imperfect: the limitations of clinical prediction models and the 
limits of clinical prediction. J Am Coil Cardiol 1989;14 Suppl A:12A-22A. 
4. Feinstein AR. Clinical Epidemiology. Philadelphia: Sounders, 1985:226-8. 
5. Brown KA, Boucher CA, Okada RD, et al. Prognostic value of exercise T1-201 imaging in 
patients presenting for evaluation ofchest pain. J Am Coil Cardiol 1983;1:994-1001. 
6. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial 
hypoperfusion as predictors of prognosis n patients with suspected coronary artery 
disease. J Am Coil Cardiol 1986;7:464-71. 
7. Kaul S, Finkelstein DM, Homma S, Leavitt M, Okada RD, Boucher CA. Superiority of
quantitative exercise thallium-201 variables indetermining long-term prognosis inambu- 
latory patients with chest pain: a comparison with cardiac atheterization. J Am Coil 
Cardiol 1988;12:25-34. 
8. Kaul S, Lilly DR, Gascho JA, et al. Prognostic utility of the exercise thallium-201 test in 
ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation 
1988;77:745-58. 
9. Pollock SG, Abbott RD, Boucher CA, Belier GA, Kaul S. Independent a d incremental 
prognostic value of tests performed in hierarchical order to evaluate patients with 
suspected coronary artery disease. Circulation 1992;85:237-48. 
10. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent a d 
incremental prognostic value of exercise ingle-photon emission computed tomographic 
(SPECT) thallium imaging incoronary artery disease. J Am Coil Cardiol 1993;22:665-70. 
11. Strattman HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise t chnetium 
99-m sestamibi tomography forcardiac risk stratification f patients with stable chest pain. 
Circulation 1994;89:615-22. 
12. Machecourt J, Longere P,Fagret D, et al. Prognostic value of thallium-201 single-photon 
emission computed tomographic myocardial perfusioo imaging according toextent of 
myocardial defect: study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol 
1994;23:1096-106. 
13. Pancholy SB, Fattah AA, Kamal AM, Ghods M, Heo J, Iskandrian AS. Independent a d 
incremental prognostic value of exercise thallium single-photon emission computed 
tomographic imaging inwomen. J Nucl Cardiol 1995;2:110-6. 
14, Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariate 
models. Ann Intern Med 1993;118:201-10. 
Cardiac Syndrome X 
I read with interest the long-term study of syndrome X by Kaski et al. 
(1) and noted that 29 of their 99 patients had hypercholesterolemia. 
Unfortunately, this comprehensive study failed to provide us with a 
detailed lipid profile of the patients; no attempt was made to treat 
them; and, moreover, the lipid issue was not addressed in their 
discussion pertaining to the possible mechanisms that may cause 
ischemia in this syndrome. Abnormal coronary vasodilation has been 
observed in hypercholesterolemic subjects without evidence of athero- 
sclerosis by either coronary angiography (2) or intravascular ultra- 
sound (3). Hypercholesterolemia ay be a dominant determinant for 
abnormal endothelium-mediated vasoactivity. Indeed cholesterol- 
lowering therapy may restore and improve ndothelial function (4). 
Thus, in this subgroup of symptomatic patients it is mandatory to 
monitor and lower their lipid levels, particularly the low density 
lipoprotein fraction, and to evaluate their clinical and exercise test 
responses to such therapy. 
EDWARD G. ABINADER, MD, FRCPI 
Cardiology Institute 
Bnai Zion Medical Center 
Technion, Medical Faculty 
47 Golomb Street 
Haifa 31048, Israel 
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Reply 
I am grateful to Abinader for his comments. We are aware of the 
effects of hyperlipidemia on endothelial function. However, an assess- 
